Insider Shareholders with Direct Ownership of Akero Therapeutics, Inc. (AKRO)
This section provides a comprehensive overview of the insiders with direct ownership of Akero Therapeutics, Inc. (AKRO). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Akero Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Andrew Cheng
President and CEO |
1,349,892 | 1,677,718 | 0 $0 | 105 |
Dec 09, 2025
Reduced 100.0%
|
|
Catriona Yale
Chief Development Officer |
378,590 | 519,476 | 0 $0 | 80 |
Dec 09, 2025
Reduced 100.0%
|
|
William Richard White
Chief Financial Officer |
558,971 | 561,003 | 0 $0 | 61 |
Dec 09, 2025
Reduced 100.0%
|
|
Timothy Rolph
Chief Scientific Officer |
500,494 | 753,932 | 0 $0 | 68 |
Dec 09, 2025
Reduced 100.0%
|
|
Jonathan Young
Chief Operating Officer |
420,267 | 606,834 | 0 $0 | 68 |
Dec 09, 2025
Reduced 100.0%
|
| 35,398 | 35,398 | 0 $0 | 4 |
Dec 09, 2025
Reduced 100.0%
|
|
| 9,398 | 9,398 | 0 $0 | 2 |
Dec 09, 2025
Reduced 100.0%
|
|
| 52,398 | 52,398 | 0 $0 | 6 |
Dec 09, 2025
Reduced 100.0%
|
|
| 9,398 | 9,398 | 0 $0 | 2 |
Dec 09, 2025
Reduced 100.0%
|
|
| 100,230 | 102,398 | 0 $0 | 3 |
Dec 09, 2025
Reduced 100.0%
|
|
| 9,398 | 314,764 | 0 $0 | 7 |
Dec 09, 2025
Reduced 100.0%
|
|
|
Apple Tree Partners Iv, L.P.
> 10% Shareholder |
0 | 5,830,203 | 0 $0 | 1 |
Jun 28, 2021
Reduced 100.0%
|
| 9,398 | 9,398 | 0 $0 | 2 |
Dec 09, 2025
Reduced 100.0%
|
|
| 59,618 | 60,179 | 0 $0 | 24 |
Dec 09, 2025
Reduced 100.0%
|
|
|
Scott A. Gangloff
Chief Technology Officer |
27,199 | 27,199 | 0 $0 | 5 |
Dec 09, 2025
Reduced 100.0%
|